Non-small cell lung cancer Trials in San Francisco, United States
Conditions / Non-small cell lung cancer / San Francisco, United States
Non-small cell lung cancer has been the subject of sustained clinical investigation across multiple research sites.
71 total trials for this combination
Showing top 10 of 71 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03452774 | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | RECRUITING | — |
| NCT02403271 | A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors | COMPLETED | PHASE1/PHASE2 |
| NCT02568267 | Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT02628535 | Safety Study of MGD009 in B7-H3-expressing Tumors | TERMINATED | PHASE1 |
| NCT03906331 | Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation | APPROVED_FOR_MARKETING | — |
| NCT03454451 | CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers | COMPLETED | PHASE1 |
| NCT04566393 | Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies | AVAILABLE | — |
| NCT01803282 | Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors | COMPLETED | PHASE1 |
| NCT02308020 | A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain | COMPLETED | PHASE2 |
| NCT05239143 | P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 |